Work

Faculty Opinions recommendation of ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.

Year: 2023

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.742675733.793599117

Author: Alejandro Schaffer

Institution: National Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4382399253

Cites:

Cited by:

Related to: 10